Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$9.4 - $16.7 $0 - $0
0 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$10.54 - $24.96 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$21.87 - $33.11 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$16.25 - $35.28 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$14.17 - $20.3 $0 - $0
0 New
0 $0

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.